Home
News
Screeners
Insights
Fabino Enterprises
20.
31
0.00
(0.00%)
Market Cap
₹4.30 Cr
PE Ratio
-7.64
Industry
Healthcare
Buy
Sell
Company Performance:
1D
0.00%
1M
0.00%
6M
+33.71%
1Y
0.00%
5Y
-49.67%
View Company Insights
Latest news about Fabino Enterprises
Fabino Enterprises discloses e-voting results for 15th AGM
1 day ago
All seven AGM resolutions passed with 100% votes in favor. Total votes polled stood at 15,11,200 shares out of 21,00,000 outstanding. Promoter group voted 11,96,200 shares, dominating the total vote count. Key approvals included FY26 financial statements and subsidiary share disposal.
Fabino Enterprises appoints three additional directors
3 days ago
Fabino Enterprises sets Sept 29 AGM; e-voting begins Sept 25
Sep 06, 2026
Fabino Enterprises approves ₹5 lakh sale of subsidiary stake
Sep 04, 2026
Fabino Enterprises accepts CS Anand Katarmal resignation effective July 7
Jul 07, 2026
More news about Fabino Enterprises
25
Jun 26
Fabino Enterprises open offer opens June 29 at ₹20 per share
Fabino Enterprises Limited's open offer for 26% equity shares at ₹20 per share opens June 29, 2026, and closes July 10, 2026. The IDC deemed the price fair, citing a VWAP of ₹15.74 and an SPA price of ₹18.00. Aryaman Financial Services Limited is the manager to the offer.
17
Jun 26
Fabino Enterprises open offer to acquire 26% at ₹20 per share
Acquirers R G Family Trust, Sameer Gupta, and Sundeep Gupta have launched a mandatory open offer to acquire 26% of Fabino Enterprises at ₹20 per share, following a prior agreement to buy 56.82% from promoters. The offer opens on June 29, 2026, and closes on July 10, 2026, with funding secured through internal resources and an escrow account.
23
May 26
Fabino FY26 Net Loss Rs 35.97 Cr, Revenue Declines
Fabino Enterprises announced its audited financial results for the year ended March 31, 2026, reporting a consolidated net loss of ₹55.87 crore compared to a net profit of ₹6.11 crore in the previous year. Standalone net loss was ₹35.97 crore, with revenue from operations falling to ₹114.28 crore from ₹180.36 crore in FY25. Key audit matters included write-offs of trade receivables and expired inventory.
13
May 26
Open Offer for 26.00% Stake in Fabino Enterprises Limited at ₹20 Per Share by R G Family Trust, Sameer Gupta and Sundeep Gupta
R G Family Trust, Sameer Gupta, and Sundeep Gupta have launched a mandatory open offer to acquire 5,46,000 equity shares (26.00%) of Fabino Enterprises Limited at ₹20/- per share in cash, following a Share Purchase Agreement to acquire 56.82% of the company's equity from promoter-group sellers at ₹18/- per share aggregating ₹2,14,77,600/-. The total offer consideration assuming full acceptance is ₹1,09,20,000/-, with an escrow of ₹30,00,000/- deposited with Yes Bank Limited. The tendering period is scheduled from June 22, 2026 to July 06, 2026, with consideration payment by July 20, 2026. Assuming full acceptance, the acquirers will hold 82.82% of Fabino Enterprises Limited's equity share capital post-offer.
06
May 26
Fabino Enterprises Open Offer for 26% Stake at ₹20/Share Scheduled June 22–July 06, 2026
R G Family Trust, Sameer Gupta, and Sundeep Gupta have launched an open offer to acquire 5,46,000 equity shares (26%) of Fabino Enterprises Limited at ₹20 per share, aggregating ₹109.20 Lakhs, under SEBI (SAST) Regulations. The offer is triggered by an SPA dated April 28, 2026 to acquire 56.82% promoter stake at ₹18 per share (₹214.78 Lakhs). The tendering period is scheduled from June 22, 2026 to July 06, 2026, with ₹30,00,000 deposited in escrow with Yes Bank Limited.
11
Apr 26
Fabino Enterprises Ltd. Confirms Non-Applicability of SEBI Large Corporate Framework for FY2027
Fabino Enterprises Ltd. has disclosed to BSE Limited that it does not fall under SEBI's Large Corporate category as of March 31, 2026, exempting it from filing disclosures under the framework for FY2026-27. The company, formerly known as Fabino Life Sciences Ltd., confirmed its non-applicability status through a formal communication signed by Managing Director Aditya Mahavir Jain on April 11, 2026. The disclosure addresses SEBI's revised framework circular dated October 19, 2023, ensuring regulatory compliance and transparency regarding the company's status.
11
Apr 26
Fabino Enterprises Ltd. Submits Q4FY26 Compliance Certificate to BSE
Fabino Enterprises Ltd. submitted its Q4FY26 compliance certificate to BSE on April 11, 2026, confirming non-applicability of SEBI Regulation 74(5) as all company shares remain in dematerialized form. The certificate, issued by registrar Bigshare Services Private Limited, reported no rematerialization or dematerialization requests during the quarter ended March 31, 2026, indicating complete digitization of the shareholding structure.
10
Apr 26
Sushma Shekhar Acquires 8.29% Stake in Fabino Enterprises Through Open Market Purchase
Sushma Shekhar acquired 174,000 shares (8.29%) of Fabino Enterprises Ltd. through open market purchase on April 9, 2026. The acquirer, who is not part of the promoter group, previously held no shares in the BSE-listed company. The acquisition has been disclosed under SEBI Regulation 29, with the company's equity capital remaining at INR 2,10,00,000 divided into 21,00,000 shares of INR 10 each.
26
Dec 25
Fabino Enterprises Independent Director Mr. Kuldeep Solanki Resigns with Immediate Effect
Fabino Enterprises Limited announced the immediate resignation of Non-Executive Independent Director Mr. Kuldeep Solanki (DIN: 07109951) effective December 26, 2025, citing pre-occupation and personal commitments. The company has informed BSE Limited under Regulation 30 of SEBI Listing Regulations and confirmed that succession planning will be addressed in the upcoming Board meeting.
26
Dec 25
Fabino Enterprises Appoints Deepali Singla as Independent Director
Fabino Enterprises Limited has appointed Mrs. Deepali Singla (DIN: 11442242) as Additional Non-Executive Independent Director effective December 26, 2025, following a board meeting. She brings over six years of professional experience as an Associate at United Lex, specializing in document review, legal research, and regulatory compliance with exposure to Supreme Court and Delhi High Court proceedings.
Fabino Enterprises
20.
31
0.0
(0.0%)
1 Year Returns:
0.00%
Industry Peers
Sun Pharmaceutical
1,801.00
(-
0.
86
%)
Divis Laboratories
9,249.00
(-
0.
46
%)
Torrent Pharmaceuticals
4,767.30
(-
0.
68
%)
Zydus Life Science
1,145.70
(-
1.
40
%)
Cipla
1,344.00
(-
0.
15
%)
Laurus Labs
1,984.00
(+
0.
20
%)
Mankind Pharma
2,535.00
(+
1.
25
%)
Dr Reddys Laboratories
1,206.20
(-
2.
17
%)
Aurobindo Pharma
1,676.80
(+
0.
29
%)
Lupin
2,031.20
(+
0.
05
%)
Get More Market Insights with
Heatmap
FII/DII
Company Filings
MF Holdings
Bulk/ Block Deals
Stock Rental via SLBM
Signals
MTF Insights
F&O Ban - MWPL
Top Deliveries
Market Valuation
IPO
Cyclical Trend
Events Calendar